Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.20828 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.17504 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.17816 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.10367 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.0346 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.35818 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33464 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.43094 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1663 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.15372 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.16425 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.15736 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.16617 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.17113 | 49 |